Chemical firm sale uses Yorkshire expertise
YORKSHIRE lawyers have played a key role in the £35m sale of pharmaceutical ingredients business Uquifa.
Uquifa has been sold by speciality chemicals group Yule Catto & Co to Indian firm Vivimed Labs.
Yule Catto & Co was advised by a team from law firm Pinsent Masons led by Leeds-based head of corporate, Europe, Martin Shaw while Dickinson Dees, led by corporate partner Philip Ashworth, represented Vivimed.
Shiv Sibal, corporate senior associate at Pinsent Masons, said: “The sale of Uquifa represents an important development for Yule Catto and will allow them to continue to focus on the growth of their polymers division following their transformational acquisition of PolymerLatex earlier this year.
“Having worked closely with them on the PolymerLatex acquisition, we are delighted to have supported Yule Catto again in achieving one of its strategic objectives.”
Uquifa, which operates through Spanish and Mexican subsidiaries, was owned by Huddersfield-based Holliday Chemical Holdings before it, in turn, was bought by Yule Catto.
Mr Ashworth said: “Vivimed Labs is a world-leading organisation with a large portfolio of pharmaceutical products and manufacturing facilities. The company has been building on its existing success through its continued acquisition strategy. In 2008, Vivimed bought the Huddersfield-based dye manufacturer James Robinson to strengthen its European presence and the Uquifa deal builds on this strategy.”
He added: “A strategic acquisition such as this with product registrations and specialised facilities, will help Vivimed to serve its export markets and global clients more effectively.”
